bpc-157 fda approval status safety warning FDA's Overreach on Compounded Peptides Gray market peptides blur drug
Description
Functional outcomes also improved with the combination treatment
The treatment administers specific peptides to mimic or supplement naturally occurring peptides
Standard daily dose: 2 mg (2000 mcg) once daily subcutaneously (FDA-approved protocol)
The addition of PRF can provides additional factors that drives stem cells towards mesenchymal tissue repair and support the microenvironment
doi: 10.1016/j.redox.2023.102674
A subcutaneous injection is used by healthcare professionals when other methods of administration are less efficient
